GHK-Cu: Molecular Structure

Molecular Structure and Properties#

GHK-Cu (glycyl-L-histidyl-L-lysine:copper(II)) is a naturally occurring tripeptide-metal complex first isolated from human plasma by Dr. Loren Pickart in 1973. It consists of three amino acids -- glycine, histidine, and lysine -- chelated to a single copper(II) ion. With a molecular weight of approximately 403.93 Da (including the copper ion), a CAS registry number of 49557-75-7, and the molecular formula C14H24CuN6O4, GHK-Cu represents one of the most extensively studied copper-peptide complexes in the biomedical literature. The free peptide (GHK, without copper) has a molecular weight of approximately 340.38 Da and is designated by CAS number 72957-37-0.

Amino Acid Sequence#

The primary sequence of GHK-Cu is a linear tripeptide: glycine-histidine-lysine (Gly-His-Lys), represented in single-letter amino acid code as GHK. Each residue contributes specific chemical functionality to the overall complex.

Glycine (position 1) provides the N-terminal amino group, which serves as one of the copper coordination sites. As the simplest amino acid with no side chain, glycine introduces minimal steric hindrance and permits flexible backbone geometry necessary for optimal metal chelation.

Histidine (position 2) is the central residue and the most critical for copper binding. Its imidazole side chain contains a nitrogen atom (N-delta or N-epsilon) that serves as the primary coordination donor to copper(II). The histidine imidazole nitrogen is the strongest donor in the complex and anchors the metal center.

Lysine (position 3) occupies the C-terminal position. While the epsilon-amino group of lysine's side chain does not directly participate in copper coordination at physiological pH, it contributes to the overall positive charge character of the peptide and influences biological interactions. The C-terminal carboxylate does not participate in copper binding in the predominant solution species at neutral pH.

Copper(II) Chelation Geometry#

The defining feature of GHK-Cu is its high-affinity chelation of copper(II). X-ray crystallographic studies and spectroscopic analyses (EPR, UV-visible, CD) have established that the copper ion adopts a square planar coordination geometry, characteristic of Cu(II) d9 complexes. The four equatorial donor atoms are:

1. The N-terminal amino nitrogen of glycine (NH2 group)
2. The deprotonated amide nitrogen between Gly and His
3. The imidazole N (N-pi or N-tau) of the histidine side chain
4. The deprotonated amide nitrogen between His and Lys

This arrangement creates two fused five-membered chelate rings, which confer exceptional thermodynamic stability to the complex. The formation of these chelate rings follows the Irving-Williams series and is strongly favored due to the ideal bite angles and donor atom arrangement.

The binding affinity of GHK for copper(II) is characterized by a conditional stability constant (log K) of approximately 16.2 at pH 7.4. This affinity is high enough to allow GHK to compete effectively with serum albumin for copper binding, yet the exchange kinetics remain sufficiently labile to permit copper transfer to target metalloenzymes such as lysyl oxidase, superoxide dismutase (SOD), and cytochrome c oxidase. This balance between tight binding and kinetic lability is central to the proposed biological function of GHK-Cu as a copper transport and delivery molecule.

Comparison with Other Copper-Binding Peptides#

GHK-Cu is not the only peptide capable of binding copper(II) in biological systems, and comparisons with related sequences illuminate its unique properties.

DAHK (Asp-Ala-His-Lys) is the N-terminal tetrapeptide of human serum albumin and represents the principal high-affinity copper(II) binding site on this abundant plasma protein. DAHK binds copper with a log K value in a similar range to GHK but operates in the context of a full 66-kDa protein. Unlike GHK-Cu, DAHK-Cu does not circulate as a free peptide-metal complex under normal physiological conditions. The coordination environment of DAHK-Cu involves the N-terminal amino nitrogen, two deprotonated amide nitrogens, and the histidine imidazole, forming a similar square planar geometry but within a different steric context.

AHK-Cu (Ala-His-Lys:copper(II)) is a synthetic analog in which glycine is replaced by alanine. This substitution introduces a methyl side chain at the N-terminal position, which can influence the copper binding geometry and kinetics. AHK-Cu has been marketed in some cosmetic formulations as an alternative to GHK-Cu, though it has a substantially smaller research base. The copper binding affinity of AHK is comparable to GHK, though subtle differences in redox behavior and biological activity have been reported.

Other copper-binding motifs in biology include the ATCUN (amino terminal copper and nickel binding) motif, which requires histidine at position 3 of the sequence (Xaa-Xaa-His). GHK differs from the canonical ATCUN motif in that histidine is at position 2 rather than position 3, resulting in a different chelate ring structure and coordination chemistry.

Physicochemical Properties#

GHK-Cu exhibits a set of physicochemical properties that facilitate its biological activity and formulation in both research and cosmetic applications.

Solubility and solution behavior: GHK-Cu is highly water-soluble due to its small size, ionic character, and the charged lysine residue. It dissolves readily in aqueous buffers across a wide pH range. The complex is most stable in mildly acidic to neutral conditions (pH 5.5-7.4), where the amide deprotonation required for copper binding is favorable and copper remains in the +2 oxidation state. At strongly acidic pH (below 3), protonation of the amide and imidazole nitrogens leads to copper release. At strongly alkaline pH (above 9), copper hydroxide precipitation may occur.

Color and spectroscopy: The characteristic blue-green color of GHK-Cu solutions arises from d-d electronic transitions of the Cu(II) ion in its square planar ligand field. This absorption band, centered near 600-650 nm, is diagnostic for the peptide-copper complex and can be used for quantification. An additional charge-transfer band near 250 nm involves nitrogen-to-copper transitions.

Degradation Pathways#

As a small peptide, GHK-Cu is susceptible to proteolytic degradation in biological environments. The estimated in vivo half-life of approximately 30-60 minutes reflects rapid cleavage by serum and tissue peptidases, particularly aminopeptidases that can attack the N-terminal glycine residue. The copper ion itself is not destroyed but is released upon peptide degradation and can be redistributed to other copper-binding proteins (albumin, ceruloplasmin) or taken up by cells.

In formulated products, GHK-Cu is relatively stable when stored as a lyophilized powder at -20 degrees C to 4 degrees C. In aqueous solution, degradation proceeds primarily through hydrolysis of the peptide bonds, with the Gly-His bond being somewhat more labile than the His-Lys bond. Oxidative degradation can also occur, particularly at the histidine residue, if the solution is exposed to reactive oxygen species. Copper itself can catalyze Fenton-type chemistry if reducing agents (such as ascorbic acid) are present, generating hydroxyl radicals that damage the peptide backbone.

For topical formulations, the pH of the vehicle is a critical factor. At the optimal pH range of 5.5-6.5 (consistent with skin surface pH), GHK-Cu maintains its copper-bound form and demonstrates acceptable chemical stability over shelf life periods of 12-24 months when properly formulated with appropriate antioxidants and chelation buffers.

Pharmacokinetics#

Formal pharmacokinetic studies of GHK-Cu in humans have not been published in the peer-reviewed literature. Estimates of the half-life (approximately 30-60 minutes) derive from in vitro stability assays and inferences from animal studies, where small peptides are generally cleared rapidly from circulation through proteolytic degradation and renal excretion of fragments.

GHK-Cu is present endogenously in human plasma at concentrations of approximately 200 ng/mL in young adults (around age 20), declining to approximately 80 ng/mL by age 60. This natural age-related decline has been hypothesized to contribute to the reduced wound healing capacity and skin quality changes observed with aging. The peptide is also found in saliva and urine at lower concentrations.

After topical application, penetration through the stratum corneum is limited by the hydrophilic nature of the peptide. Enhancement strategies including iontophoresis, microneedling, and liposomal encapsulation have been explored to improve dermal delivery. Systemic absorption following topical application is considered negligible under standard cosmetic use conditions.

Conclusion#

GHK-Cu is a well-characterized tripeptide-copper(II) complex with a defined coordination chemistry, favorable aqueous solubility, and a biological profile that reflects its dual function as both a signaling peptide and a copper delivery vehicle. Its high-affinity yet kinetically labile copper binding, combined with its natural presence in human plasma and documented age-related decline, positions GHK-Cu as a molecule of considerable interest for wound healing, skin rejuvenation, and tissue remodeling research. Understanding its molecular properties is essential for rational formulation and for interpreting its biological activity in both preclinical and cosmetic studies.

Related Reading#

• GHK-Cu overview and research guide
• Peptides similar to GHK-Cu
• GHK-Cu research evidence